Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Non-Current Assets (2023 - 2025)

Metagenomi (MGX) has disclosed Non-Current Assets for 3 consecutive years, with $55.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 16.62% to $55.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $239.0 million, a 20.55% decrease, with the full-year FY2025 number at $55.6 million, down 16.62% from a year prior.
  • Non-Current Assets was $55.6 million for Q4 2025 at Metagenomi, down from $58.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $86.6 million in Q4 2023 to a low of $55.6 million in Q4 2025.
  • A 3-year average of $69.6 million and a median of $66.6 million in 2024 define the central range for Non-Current Assets.
  • Biggest YoY gain for Non-Current Assets was 16.62% in 2025; the steepest drop was 23.59% in 2025.
  • Metagenomi's Non-Current Assets stood at $86.6 million in 2023, then fell by 23.02% to $66.6 million in 2024, then decreased by 16.62% to $55.6 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Non-Current Assets are $55.6 million (Q4 2025), $58.1 million (Q3 2025), and $60.6 million (Q2 2025).